Generex Biotechnology Corp (GNBT) financial statements (2021 and earlier)

Company profile

Business Address 10102 USA TODAY WAY
MIRAMAR, FL 33025
State of Incorp. DE
Fiscal Year End July 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0013013
Cash and cash equivalents0013013
Inventory, net of allowances, customer advances and progress billings1000   
Inventory1000   
Intangible current assets     00
Other current assets1000000
Other undisclosed current assets000  (0)(0)
Total current assets:2113013
Noncurrent Assets
Operating lease, right-of-use asset0 
Property, plant and equipment0000000
Intangible assets, net (including goodwill)413933 12
Goodwill3938     
Intangible assets, net (excluding goodwill)2133 12
Other undisclosed noncurrent assets9924   
Total noncurrent assets:504957012
TOTAL ASSETS:5250710026
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:24191110988
Accounts payable    433
Accrued liabilities    000
Employee-related liabilities    000
Other undisclosed accounts payable and accrued liabilities24191110544
Debt12      
Derivative instruments and hedges, liabilities      3
Deferred revenue and credits   0
Other undisclosed current liabilities21014140 (3)
Total current liabilities:38292524988
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0 
Liabilities, other than long-term debt108  223
Derivative instruments and hedges, liabilities108  223
Other undisclosed noncurrent liabilities0(7)2566001
Total noncurrent liabilities:1112566233
Other undisclosed liabilities 8     
Total liabilities:48385090111112
Temporary equity, carrying amount44     
Stockholders' equity
Stockholders' equity attributable to parent, including:(0)8(44)(80)(11)(8)(6)
Common stock0000111
Common stock, share subscribed but unissued, subscriptions receivable(1)      
Additional paid in capital420409368368363363362
Accumulated other comprehensive income1111111
Accumulated deficit(435)(419)  (376)(372) 
Warrants and rights outstanding     2 
Other undisclosed stockholders' equity attributable to parent1417(413)(449) (2)(370)
Total stockholders' equity:(0)8(44)(80)(11)(8)(6)
TOTAL LIABILITIES AND EQUITY:5250710026

Income statement (P&L) ($ in millions)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
Revenues361    
Cost of revenue(2)(4)    (1)
Cost of goods and services sold (1)    (1)
Gross profit:121   (1)
Operating expenses(27)(26)(3)(2)(2)(4)(4)
Other undisclosed operating income0     1
Operating loss:(26)(24)(2)(2)(2)(4)(4)
Nonoperating income
(Investment Income, Nonoperating)
  1  00
Interest and debt expense(9)(7)(1)(1)(0)(0)(0)
Loss before gain (loss) on sale of properties:(35)(31)(2)(2)(2)(4)(5)
Other undisclosed net income     25
Net loss:(35)(31)(2)(2)(2)(2)(0)
Net income attributable to noncontrolling interest2207   
Other undisclosed net income (loss) attributable to parent01938(81)(1)  
Net income (loss) attributable to parent:(33)(11)36(77)(3)(2)(0)
Preferred stock dividends and other adjustments     (0)(2)
Other undisclosed net income available to common stockholders, basic2207   
Net income (loss) available to common stockholders, diluted:(31)(9)36(70)(3)(3)(2)

Comprehensive Income ($ in millions)

1/31/2020
TTM
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
7/31/2014
Net loss:(35)(31)(2)(2)(2)(2)(0)
Comprehensive loss:(35)(31)(2)(2)(2)(2)(0)
Comprehensive income, net of tax, attributable to noncontrolling interest2207   
Other undisclosed comprehensive income, net of tax, attributable to parent     0 
Comprehensive income (loss), net of tax, attributable to parent:(33)(30)(2)4(2)(2)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: